| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1749-6632.1999.TB08022.X |
| P698 | PubMed publication ID | 10668448 |
| P2093 | author name string | J R Harris | |
| F Nicoletti | |||
| A Bond | |||
| G Battaglia | |||
| D D Schoepp | |||
| J A Monn | |||
| V Bruno | |||
| M J O'Neill | |||
| D Lodge | |||
| A E Kingston | |||
| B P Clark | |||
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 12 | |
| P304 | page(s) | 438-449 | |
| P577 | publication date | 1999-01-01 | |
| P1433 | published in | Annals of the New York Academy of Sciences | Q2431664 |
| P1476 | title | Neuroprotective actions of novel and potent ligands of group I and group II metabotropic glutamate receptors | |
| P478 | volume | 890 |
| Q43668123 | Activation of groups I or III metabotropic glutamate receptors inhibits excitatory transmission in the rat subthalamic nucleus |
| Q38700682 | Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP, Long-Term Potentiation, and Disrupts Memory Reconsolidation |
| Q47651047 | Disturbance of Metabotropic Glutamate Receptor-Mediated Long-Term Depression (mGlu-LTD) of Excitatory Synaptic Transmission in the Rat Hippocampus After Prenatal Immune Challenge |
| Q48371575 | Evaluation of [3H]LY341495 for labeling group II metabotropic glutamate receptors in vivo |
| Q37200841 | G-protein-coupled receptors and melanoma |
| Q34103957 | Glutamate receptors, neurotoxicity and neurodegeneration |
| Q43774336 | Immunohistochemical localization of group I and II metabotropic glutamate receptors in control and amyotrophic lateral sclerosis human spinal cord: upregulation in reactive astrocytes. |
| Q36501535 | Increased locomotor activity and non-selective attention and impaired learning ability in SD rats after lentiviral vector-mediated RNA interference of Homer 1a in the brain |
| Q46729659 | Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. |
| Q43694465 | Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways. |
| Q48538143 | The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats |
| Q34725251 | The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. |
| Q36003895 | The role of group I metabotropic glutamate receptors in neuronal excitotoxicity in Alzheimer's disease |
| Q80725712 | The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection |
| Q35698522 | Therapeutic potential of mGluR5 targeting in Alzheimer's disease |
| Q34922378 | mGluR5 and NMDA receptors drive the experience- and activity-dependent NMDA receptor NR2B to NR2A subunit switch |
Search more.